Beijing Konruns Pharmaceutical Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 448.95 million compared to CNY 355.84 million a year ago. Revenue was CNY 450.84 million compared to CNY 371.59 million a year ago.

Net income was CNY 92.89 million compared to CNY 82.04 million a year ago. Basic earnings per share from continuing operations was CNY 0.59 compared to CNY 0.52 a year ago. Diluted earnings per share from continuing operations was CNY 0.59 compared to CNY 0.52 a year ago.